好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Feasibility of a Smartphone-based EEG Recording System for Neurological Evaluation in Kenya
Epilepsy/Clinical Neurophysiology (EEG)
P2 - Poster Session 2 (11:45 AM-12:45 PM)
10-001

To report findings from >2000 point-of-care smartphone-based electroencephalography (EEG) recordings in Kenya in routine clinical settings.

Access to EEG services remains limited in many low- and middle-income countries (LMICs) because of cost, infrastructure needs, and shortage of trained staff. BrainCapture’s BC-1 is a smartphone-based EEG system designed to enable non-specialist workers to record EEGs with remote expert interpretation.

Standardized 30-minute, 27-lead, asleep and awake scalp EEGs were performed on patients of any age clinically seen across 20 hospitals in Kenya. Primary indications included convulsions (72%), altered consciousness/headache (12%), or other suspected seizure-related events (16%). Each recording was collected by a trained allied healthcare worker and subsequently evaluated by clinical neurophysiologists for (1) quality of recording, (2) presence of epileptiform discharges, and (3) other abnormal EEG findings. Demographic variables included age group (≤3 years, 4-11 years, 12-18 years, 19-50 years, and ≥51 years) and sex.

A total of 2162 EEG recordings were performed. 1199 (58%) of the patients were male. 2076 (96%) of the recordings met interpretation standards, with a total of 618 (30%) of the recordings reported as abnormal, 458 (22%) displaying epileptiform activity and 160 (8%) indicating other abnormal activity. Among children ≤3 years old, 28% had abnormal EEGs and 23% showed epileptiform activity; ages 4–11 years (38% abnormal and 32% epileptiform); ages 12–18 years (34% abnormal and 28% epileptiform); adults 19-50 years (23% abnormal and 14% epileptiform); and adults ≥51 years (30% abnormal and 15% epileptiform). 

A substantial number of EEGs showed clinically relevant abnormal activity. These findings demonstrate the feasibility and implementation of EEG acquisition in Kenya using a point-of-care remote interpretation system. Expansion of the use of the BrainCapture system may improve diagnostic confirmation, direct treatment, and inform care in additional LMICs and other resource limited settings.

Authors/Disclosures
Nomin Enkhtsetseg
PRESENTER
Ms. Enkhtsetseg has nothing to disclose.
William Lehn-Schioeler Mr. Lehn-Schioeler has received personal compensation for serving as an employee of BrainCapture.
JULES FIDELE U. NSHIMIYIMANA, MD Dr. NSHIMIYIMANA has received personal compensation in the range of $0-$499 for serving as a Consultant for BRAIN CAPTURE.
Tue Lehn-Schioeler, PhD Mr. Lehn-Schioeler has received personal compensation for serving as an employee of BrainCapture. Mr. Lehn-Schioeler has stock in BrainCapture.
George Wambugu, Neurophysiology Technologist Mr. Wambugu has received personal compensation for serving as an employee of BrainCapture Kenya.
Sidsel A. Larsen Mrs. Larsen has received research support from BrainCapture ApS .
Sandor Beniczky, MD, PhD (Aarhus University & Danish Epilepsy Center) Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Prof. Beniczky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW. The institution of Prof. Beniczky has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE.
Farrah J. Mateen, MD, PhD, FAAN (Northwestern University Department of Neurology) Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.